Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027819 (
neuroblastoma
)
27,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
1. 12-Lipoxygenase produces 12-hydroperoxy acid from arachidonic acid released from membrane phospholipids. To elucidate the role of the enzyme in neuronal functions, mouse
neuroblastoma
x rat glioma hybrid NG108-15 cells were permanently transfected with the cDNA for human
12-lipoxygenase
. 2. The number of action potentials evoked by depolarizing current steps in a current-clamp mode was strikingly increased in
12-lipoxygenase
-expressing NG108-15 cells as compared with the wild-type cells which hardly had the enzyme activity. 3. In the transformed cells, the M-type voltage-dependent K+ current was significantly reduced with little or no change in other ion channel currents. 4. Treatment of the transformed cells with a
12-lipoxygenase
inhibitor recovered the action potential frequency and the M-current amplitude to the control level. 5. These results indicate that
12-lipoxygenase
and/or its metabolites target K+ channels and upregulate the membrane excitability, and thereby modulate neuronal signalling.
...
PMID:12-Lipoxygenase overexpression in rodent NG108-15 cells enhances membrane excitability by inhibiting M-type K+ channels. 1060 89
Synthetic retinoids such as fenretinide [N-(4-hydroxyphenyl)retinamide] induce apoptosis of
neuroblastoma
cells, act synergistically with chemotherapeutic drugs, and may provide opportunities for novel approaches to
neuroblastoma
therapy. Fenretinide-induced cell death of
neuroblastoma
cells is caspase dependent and results in the release of cytochrome c from mitochondria independently of changes in permeability transition. This is mediated by a signaling pathway characterized by the generation of reactive oxygen species (ROS) via
12-lipoxygenase
(
12-LOX
), and an oxidative-stress-dependent induction of the transcription factor, GADD153 and the BCL2-related protein BAK. Upstream events of fenretinide-induced signaling involve increased levels of ceramide as a result of increased sphingomyelinase activity, and the subsequent metabolism of ceramide to gangliosides via glucosylceramide synthase and GD3 synthase. These gangliosides may be involved in the regulation of
12-LOX
leading to oxidative stress and apoptosis via the induction of GADD153 and BAK. The targeting of sphingomyelinases or downstream effectors such as
12-LOX
or GADD153 may present novel approaches for the development of more effective and selective drugs for
neuroblastoma
therapy.
...
PMID:Molecular mechanisms of fenretinide-induced apoptosis of neuroblastoma cells. 1565 Feb 34
Fenretinide induces apoptosis in SH-SY5Y
neuroblastoma
cells via a signaling pathway involving the production of reactive oxygen species (ROS),
12-lipoxygenase
activity and the induction of the GADD153 transcription factor. NF-kappa B is a key element of many cell signaling pathways and adopts a pro- or anti-apoptotic role in different cell types. Studies have suggested that NF-kappa B may play a pro-apoptotic role in SH-SY5Y cells, and in other cell types NF-kappa B activation may be linked to lipoxygenase activity. The aim of this study was to test the hypothesis that NF-kappa B activity mediates fenretinide-induced apoptosis in SH-SY5Y
neuroblastoma
cells. Using a dominant-negative construct for Ikappa Balpha stably transfected into SH-SY5Y cells, we show that apoptosis, but not the induction of ROS, in response to fenretinide was blocked by abrogation of NF-kappa B activity. In parental SH-SY5Y cells, fenretinide induced NF-kappa B activity and Ikappa Balpha phosphorylation. These results suggest that NF-kappa B activity links fenretinide-induced ROS to the induction of apoptosis in SH-SH5Y cells, and may be a target for the future development of drugs for
neuroblastoma
therapy.
...
PMID:The NF-kappaB pathway mediates fenretinide-induced apoptosis in SH-SY5Y neuroblastoma cells. 1590 11